CHARLOTTE, N.C., May 14, 2026 (GLOBE NEWSWIRE) -- Adaptin Bio, Inc. (OTCQB: APTN), (“Adaptin” or the “Company”), a biotechnology company…
New ticker aligns with new $1 billion strategy for XRP exposure on NASDAQ MIAMI, Oct. 29, 2025 /PRNewswire/ -- Armada Acquisition…
Dan Ives, renowned technology and AI expert and Wall Street analyst, to serve as Chairman of the Board In an…